Get the latest tech news

Microbiome startups respond as industry is accused of ‘questionable practices’

The biotech sector has embraced the microbiome in recent years, a green field market powered by cheap genome sequencing and venture dollars, promising

The biotech sector has embraced the microbiome in recent years, a green field market powered by cheap genome sequencing and venture dollars, promising bespoke treatments for everything from gut troubles to skin problems. This may be strictly true, but it must be said that it does offer to “Prevent or manage microbiome-related conditions like colic, eczema, food allergies, asthma, constipation and more,” admittedly with the support of a doctor, but some recommendations like exposure to pets, are made in-app. “Daye’s test enables us to measure the relative abundance of good bacteria, as well as that of opportunistic microorganisms, that cause BV and yeast infections when found in large amounts,” she continued, but this is only one step in a clinician-involved process that must identify the specific pathogen before recommending a treatment.

Get the Android app